LINC01354
gene geneOn this page
Summary
LINC01354 (long intergenic non-protein coding RNA 1354, HGNC:50581) is a long non-coding RNA gene on chromosome 1q42.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50581 |
| Approved symbol | LINC01354 |
| Name | long intergenic non-protein coding RNA 1354 |
| Location | 1q42.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000231768 |
| Ensembl biotype | lncRNA |
| Entrez | 100506795 |
| RNAcentral | URS0000048444 — lncRNA, 2860 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 21 lncRNA
ENST00000421207, ENST00000435574, ENST00000653099, ENST00000653353, ENST00000663964, ENST00000665108, ENST00000804324, ENST00000804325, ENST00000804326, ENST00000804327, ENST00000804328, ENST00000804329, ENST00000804330, ENST00000804331, ENST00000804332, ENST00000804333, ENST00000804334, ENST00000804335, ENST00000804336, ENST00000804337, ENST00000804338
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000421207 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001616556 | 234529825 | 234530342 |
| ENSE00003858577 | 234531016 | 234531792 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 73.17.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3493 / max 27.6317, expressed in 139 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 18044 | 0.2011 | 77 |
| 18043 | 0.1481 | 82 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 73.17 | gold quality |
| body of pancreas | UBERON:0001150 | 71.57 | gold quality |
| caudate nucleus | UBERON:0001873 | 69.02 | gold quality |
| popliteal artery | UBERON:0002250 | 68.76 | gold quality |
| amygdala | UBERON:0001876 | 68.74 | gold quality |
| tibial artery | UBERON:0007610 | 68.70 | gold quality |
| ascending aorta | UBERON:0001496 | 68.59 | gold quality |
| aorta | UBERON:0000947 | 68.50 | gold quality |
| thoracic aorta | UBERON:0001515 | 68.49 | gold quality |
| right coronary artery | UBERON:0001625 | 68.28 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 68.28 | gold quality |
| hypothalamus | UBERON:0001898 | 68.19 | gold quality |
| pancreas | UBERON:0001264 | 67.45 | gold quality |
| left coronary artery | UBERON:0001626 | 66.40 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 65.88 | gold quality |
| nucleus accumbens | UBERON:0001882 | 65.86 | gold quality |
| coronary artery | UBERON:0001621 | 65.46 | gold quality |
| putamen | UBERON:0001874 | 65.41 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 65.24 | gold quality |
| Ammon’s horn | UBERON:0001954 | 64.15 | gold quality |
| ventricular zone | UBERON:0003053 | 64.04 | gold quality |
| substantia nigra | UBERON:0002038 | 63.95 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 63.80 | gold quality |
| spinal cord | UBERON:0002240 | 63.74 | gold quality |
| body of uterus | UBERON:0009853 | 63.67 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 63.41 | gold quality |
| temporal lobe | UBERON:0001871 | 62.64 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 62.46 | gold quality |
| lower esophagus | UBERON:0013473 | 62.35 | gold quality |
| amniotic fluid | UBERON:0000173 | 62.01 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- LINC01354 was upregulated in CRC tissues and high level of LINC01354 was associated with poor prognosis of CRC patients. Gain- and loss-of-function assays illustrated that LINC01354 acted as an oncogene in CRC to facilitate tumor cell proliferation, inhibited apoptosis, and promoted cell migration and invasion in an hnRNP-D/Wnt/beta-catenin-dependent manner (PMID:30987669)
- LINC01354 enhances the proliferation and invasion of lung cancer cells by regulating miR-340-5p/ATF1 signaling pathway (PMID:31538498)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.